Giuseppe Caruso, Gynecology Oncology Specialist at European Institute of Oncology, shared a post a post on LinkedIn:
“One month to go until ESMO Gynae 2026 in Copenaghen. Excited to join as discussant on MIRV and the evolving role of ADCs in the platinum-eligible ovarian cancer setting.
What is happening in our field is truly a tsunami. We are playing a new board game with ADCs – ‘ADC-opoly’ – and reshaping treatment algorithms.”
Other articles about ESMO on OncoDaily.
